Diagnostics & Research
The Diagnostics & Research industry has a total of 50 stocks, with a combined market cap of $599.09 billion, total revenue of $161.32 billion and a weighted average PE ratio of 48.32.
Market Cap
599.09B
Revenue
161.32B
Profits
12.4B
PE Ratio
48.32
Profit Margin
7.69%
Dividend Yield
0.31%
50 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 148.19B | 0.59% | 2,884,090 | 42.90B |
| 2 | DHR | Danaher Corporation | 139.15B | -0.67% | 3,236,195 | 23.82B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 41.81B | -0.14% | 412,946 | 3.93B |
| 4 | A | Agilent Technologies, Inc. | 32.82B | -0.49% | 1,560,260 | 6.63B |
| 5 | IQV | IQVIA Holdings Inc. | 26.75B | 0.33% | 1,666,913 | 15.50B |
| 6 | MTD | Mettler-Toledo International Inc. | 23.81B | -0.44% | 125,737 | 3.83B |
| 7 | NTRA | Natera, Inc. | 23.35B | 2.05% | 1,967,782 | 1.83B |
| 8 | LH | Labcorp Holdings Inc. | 21.88B | 0.75% | 597,371 | 13.18B |
| 9 | WAT | Waters Corporation | 20.20B | -0.51% | 359,854 | 2.98B |
| 10 | DGX | Quest Diagnostics Incorporated | 20.07B | 0.46% | 618,901 | 10.16B |
| 11 | ILMN | Illumina, Inc. | 14.29B | 0.88% | 1,980,727 | 4.34B |
| 12 | ICLR | ICON Public Limited Company | 11.41B | 1.21% | 1,131,422 | 8.19B |
| 13 | RVTY | Revvity, Inc. | 11.13B | 0.27% | 985,765 | 2.77B |
| 14 | QGEN | Qiagen N.V. | 10.08B | - | 870,326 | 2.00B |
| 15 | EXAS | Exact Sciences Corporation | 9.87B | -0.38% | 2,869,312 | 2.83B |
| 16 | MEDP | Medpace Holdings, Inc. | 8.70B | 1.60% | 655,752 | 2.16B |
| 17 | CRL | Charles River Laboratories International, Inc. | 7.14B | 0.17% | 632,961 | 4.02B |
| 18 | GH | Guardant Health, Inc. | 6.27B | 2.10% | 2,919,826 | 774.00M |
| 19 | RDNT | RadNet, Inc. | 4.29B | 0.99% | 577,887 | 1.87B |
| 20 | SHC | Sotera Health Company | 3.11B | -0.05% | 1,458,374 | 1.11B |
| 21 | TWST | Twist Bioscience Corporation | 2.15B | 5.81% | 1,072,298 | 347.68M |
| 22 | VCYT | Veracyte, Inc. | 2.10B | 0.22% | 675,297 | 463.39M |
| 23 | WGS | GeneDx Holdings Corp. | 1.84B | 0.61% | 684,923 | 330.14M |
| 24 | GRAL | GRAIL, Inc. | 1.74B | 15.20% | 2,343,049 | 130.71M |
| 25 | NEOG | Neogen Corporation | 1.08B | -5.49% | 6,482,694 | 906.00M |
| 26 | CDNA | CareDx, Inc | 1.06B | -2.51% | 919,421 | 346.42M |
| 27 | OPK | OPKO Health, Inc. | 1.02B | - | 3,718,246 | 689.41M |
| 28 | NEO | NeoGenomics, Inc. | 894.43M | -0.64% | 1,947,985 | 672.36M |
| 29 | FLGT | Fulgent Genetics, Inc. | 618.00M | 0.20% | 167,386 | 292.45M |
| 30 | PSNL | Personalis, Inc. | 576.76M | 4.82% | 1,287,289 | 85.69M |
| 31 | CSTL | Castle Biosciences, Inc. | 545.98M | 2.00% | 335,183 | 347.08M |
| 32 | MYGN | Myriad Genetics, Inc. | 467.34M | 1.81% | 1,987,368 | 831.30M |
| 33 | XGN | Exagen Inc. | 160.85M | -4.79% | 290,064 | 56.72M |
| 34 | PRE | Prenetics Global Limited | 120.69M | 23.30% | 381,039 | 41.52M |
| 35 | MDXH | MDxHealth SA | 100.48M | 3.05% | 88,342 | 94.51M |
| 36 | FONR | FONAR Corporation | 88.52M | -1.99% | 17,800 | 103.02M |
| 37 | NOTV | Inotiv, Inc. | 74.55M | 5.85% | 567,639 | 480.40M |
| 38 | BDSX | Biodesix, Inc. | 40.48M | -2.92% | 1,505,194 | 74.46M |
| 39 | BNR | Burning Rock Biotech Limited | 40.05M | 4.53% | 9,309 | 72.11M |
| 40 | ADVB | Advanced Biomed Inc. | 16.77M | -7.06% | 100,039 | - |
| 41 | PRPO | Precipio, Inc. | 16.41M | - | 998 | 20.03M |
| 42 | PRPH | ProPhase Labs, Inc. | 15.22M | 4.69% | 3,693,184 | 5.85M |
| 43 | BIAF | bioAffinity Technologies, Inc. | 6.91M | -6.55% | 9,248,105 | 8.81M |
| 44 | STRR | Star Equity Holdings, Inc. | 6.39M | - | 3,942 | 57.17M |
| 45 | MYNZ | Mainz Biomed N.V. | 5.26M | -3.16% | 79,688 | 893.99K |
| 46 | XWEL | XWELL, Inc. | 4.76M | 0.43% | 9,438 | 32.19M |
| 47 | CHEK | Check-Cap Ltd. | 4.31M | -4.04% | 18,133 | - |
| 48 | APDN | Applied DNA Sciences, Inc. | 2.46M | - | 21,495 | 3.79M |
| 49 | ISPC | iSpecimen Inc. | 2.45M | -0.81% | 28,368 | 8.06M |
| 50 | NDRA | ENDRA Life Sciences Inc. | 2.37M | -3.31% | 11,674 | - |